Company Overview and News

 
ASX suffers worst week in two months

15h theage.com.au
The S&P/ASX 200 index fell 4.3 points, or 0.1 per cent, on Friday to 6032.8, down 54.6 points, or 0.9 per cent, for the week.

 
The world wants more camel milk? Ex-BHP engineer is happy to supply it

15h theage.com.au
Marcel Steingiesser gave up a 14-year career at the world's biggest mining company to stake his future on what he says is an even better opportunity - Australian camel milk.

 
Markets Live: ASX falls on resource sector

15h theage.com.au
The S&P/ASX 200 index fell 4.3 points, or 0.1 per cent, on Friday to 6032.8, down 54.6 points, or 0.9 per cent for the week.

 
ASX suffers worst week in two months

15h smh.com.au
The S&P/ASX 200 index fell 4.3 points, or 0.1 per cent, on Friday to 6032.8, down 54.6 points, or 0.9 per cent, for the week.

 
The world wants more camel milk? Ex-BHP engineer is happy to supply it

15h smh.com.au
Marcel Steingiesser gave up a 14-year career at the world's biggest mining company to stake his future on what he says is an even better opportunity - Australian camel milk.

 
Markets Live: ASX falls on resource sector

15h smh.com.au
The S&P/ASX 200 index fell 4.3 points, or 0.1 per cent, on Friday to 6032.8, down 54.6 points, or 0.9 per cent for the week.

 
Sterlite protests land a blow to Vedanta boss Anil Agarwal’s ambitions

15h livemint
New Delhi: Indian billionaire Anil Agarwal often talks about his dream to turn his London-listed company Vedanta Resources Plc into a global resources giant. He has already bought stakes in big mining companies, such as Anglo American Plc, and says he plans to spend at least $1 billion on investments in Africa.

 
Deadly protests land a blow to Indian resources magnate Agarwal's ambitions

15h channelnewsasia
Indian billionaire Anil Agarwal often talks about his dream to turn his London-listed company Vedanta Resources into a global resources giant. He has already bought stakes in big mining companies, such as Anglo American Plc, and says he plans to spend at least US$1 billion on investments in Africa.

 
BHP Billiton Braves Iron-Ore Price Slump on Robust Yield

2018-05-23 zacks
On May 22, we issued an updated research report on premium basic materials company — BHP Billiton Limited (BHP - Free Report) . The stock currently carries a Zacks Rank #3 (Hold), but flaunts a VGM Score of A. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Let's dig a little deeper into the fundamental factors of the stock. Gaining on Higher Productivity & Liquidity Over the past five years, BHP Billiton has gathered productivity gains worth $12 billion.

 
Colombia coal output falls 11.7 pct in Q1 to 19.6 mln tonnes

2018-05-23 reuters
BOGOTA, May 23 (Reuters) - Colombia, the world’s fifth-largest exporter of coal, produced 19.6 million tonnes in the first quarter, down 11.7 percent from output the year before, the Energy and Mining Ministry said in a statement on Wednesday.

 
ASX drops for a fifth straight session

2018-05-23 theage.com.au
Australian shares have closed the day lower despite a positive performance in early trade as it recorded its fifth consecutive fall.

 
ASX drops for a fifth straight session

2018-05-23 smh.com.au
Australian shares have closed the day lower despite a positive performance in early trade as it recorded its fifth consecutive fall.

 
Midas Gold Increases Board Size to Eight & Appoints an Additional Director

2018-05-22 globenewswire
VANCOUVER, British Columbia, May 22, 2018 (GLOBE NEWSWIRE) -- Midas Gold Corp. (TSX:MAX) (OTCQX:MDRPF) (“Midas Gold” or the “Company”) today announced that it has increased the size of its board of directors from seven to eight and appointed Mark Hill, Chief Investment Officer with Barrick Gold Corporation (NYSE:ABX) (TSX:ABX) (“Barrick”) to fill the additional position. The increase in board size and the appointment of a Barrick nominee to the board of directors is in accordance with the terms of the investor rights agreement entered into with Barrick in conjunction with the strategic investment by Barrick in Midas Gold that was completed on May 16, 2018.

 
Investor Confidence In Higher Copper Remains Strong

2018-05-21 seekingalpha
Copper equities have rallied significantly since last year, while the copper price is up 17% year-to-date.

 
BHP's EV Plans For Nickel West - More Than Putting Lipstick On A Pig

2018-05-20 seekingalpha
In August 2017, BHP Billiton (BHP) revealed plans to join the EV boom by investing USD 43mn in a sulfate plant at the Kwinana refinery in Western Australia, which forms part of its Nickel West division. With an annual capacity of 100,000 tonnes per year, it could be the world’s largest nickel sulfate plant. First production is expected in April 2019 and BHP said that it was also considering a stage two expansion of the nickel sulphate plant to 200,000 tonnes per year depending on industry demand.

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

16h - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

17h - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...